Drug Shortage Report for ALOXI

Last updated on 2021-09-25 History
Report ID 145567
Drug Identification Number 02381729
Brand name ALOXI
Common or Proper name palonosetron hydrochloride
Company Name KNIGHT THERAPEUTICS INC.
Market Status DORMANT
Active Ingredient(s) PALONOSETRON
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 1
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2021-09-13
Actual start date 2021-09-13
Estimated end date 2021-09-30
Actual end date 2021-09-24
Shortage status Resolved
Updated date 2021-09-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3400 DE MAISONNEUVE BLVD W
MONTREAL, QUEBEC
CANADA H3Z 3B8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-09-13 English Compare
v2 2021-09-13 French Compare
v3 2021-09-14 English Compare
v4 2021-09-24 English Compare
v5 2021-09-24 French Compare
v6 2021-09-25 English Compare

Showing 1 to 6 of 6